Friday March 1, 2019

14.00 ORAL PRESENTATION SESSION
Chairs: Marco Confalonieri (Trieste, Italy), Olivier Sitbon (Paris, France)
 

SCREENING AND ITS CONSEQUENCES IN RARE PULMONARY DISEASES

Chairs: Bruno Crestani (Paris, France), Nazzareno Galiè (Bologna, Italy),Paolo Spagnolo (Padua, Italy)

14.00 18F-FDG PET/CT mapping in Sarcoidosis Emerging Patterns and Phenotypes from a Greek study
Spyros A. Papiris, Alexandros Georgakopoulo, Andriana I Papaioannou, Nikoletta K Pianou, Maria Kallergi, Nikolaos L. Kelekis, Helias Gialafos, Effrosyni D. Manali, Sofia Chatziioannou (Athens, Greece)

14.00 18F-FDG PET/CT in lung sarcoidosis: Total Lesion Glycolysis metric of inflammation burden
Spyros A. Papiris SA, Effrosyni D. Manali, Nikoletta K. Pianou, Maria Kallergi, Andriana I. Papaioannou, Alexandros Georgakopoulo, Katerina Malagari, Nikolaos L. Kelekis, Helias Gialafos, Sofia Chatziioannou (Athens, Greece)

14.20 Peripheral oxidative burst correlates with serum VEGF levels in idiopathic pulmonary fibrosis: effect of anti-fibrotic drug therapy
G. E. Polistina, S. Zanotta, G.Rea, A. Coppola, D. Galati, M. Bocchino (Naples, Italy)

14.30 Pleuroparenchymal fibroelastosis with an UIP pattern:considerations on a group of patients
Gaetano Rea, Alessandro Sanduzzi Zamparelli, Marialuisa Bocchino (Naples,Italy)

14.40 Datamining in the Alpha-1 International Registry (AIR).
Jan Stolk (Leiden, NL)

14.50 Differences in symptoms and cardiopulmonary responses to treadmill and cycle cardiopulmonary exercise testing (CPET) in ILD and comparison with the 6MWT
D. Nikoletou, I. Chis-Ster, M. Papadakis, C.Y. Lech, I.S. McNaughton, F. Chua, R. Aul, P. Jones (London, UK)

15.00 Echocardiographyc evaluation of right ventricle subclinical dysfunction in interstitial lung disease patients
Angelo Canora, Agostino Buonauro, Pasquale Dolce, Marialuisa Bocchino, Alessandro Sanduzzi Zamparelli (Naples, Italy)

 

SCREENING AND ITS CONSEQUENCES IN RARE PULMONARY DISEASES

Chairs: Bruno Crestani (Paris, France), Nazzareno Galiè (Bologna, Italy), Paolo Spagnolo (Padua, Italy)

15.20 Screening for pulmonary arterial hypertension in systemic sclerosis and in BMPR2 mutation carriers
Marc Humbert (Paris, France)

15.40 Screening for cystic fibrosis
Guillaume Thouvenin (Paris, France)

16.00 Screening for alpha-1 antitrypsine deficiency
Jan Stolk (Leiden, The Netherlands)

16.20 Screening for mesothelioma
Robin Cornelissen (Rotterdam, The Netherlands)

16.40 Discussion

17.00 End of the first day sessions